Abstract
Increasing evidence supports the influence of sex hormones on the central nervous system’s (CNS) plasticity and mental state. Indeed, gender differences have been described in proneness to many psychiatric and neurological diseases, among which differences in incidence between men and women have been reported. In addition, biological aspects can affect the clinical presentation of some mental diseases. In fact, changes in hormonal levels across the life span may also affect mental illness expression.
The present contribution is aimed at summarizing the possible interplay between gonadal hormones and mental health. In particular, sex hormones may be relevant in mentally ill patients for three reasons: (1) they can play a role in the pathophysiology of psychiatric disorders; (2) they may be used to treat mental illness; and (3) treatment with sex hormones may have psychiatric side effects. The available literature exploring the relationship between sex hormones and psychiatric conditions highlights the importance of a multidisciplinary assessment in mentally ill patients. Prospective randomized studies investigating the impact of hormone replacement therapy on psychological profiles may provide crucial information in better understanding sex hormones’ influences on mental state, as well as optimizing treatments in mentally vulnerable patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kulkarni J, Gurvich C, Gilbert H, Mehmedbegovic F, Mu L, Marston N, Gavrilidis E, de Castella A, Aust NZ. Hormone modulation: a novel therapeutic approach for women with severe mental illness. J Psychiatry. 2008;42(1):83–8.
Cohen-Bendahan CC, van de Beeka C, Berenbaum SA. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev. 2005;29:353–84.
Raznahan A, Lee Y, Stidd R, Long R, Greenstein D, Clasen L, Addington A, Gogtay N, Rapoport JL, Giedd JN. Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. Proc Natl Acad Sci U S A. 2010;107:16988–93.
Golightly L, Young A. Sex hormones and mental health. Adv Psychiatr Treat. 1995;5:126–34.
Gobinath AR, Choleris E, Galea LA. Sex, hormones, and genotype interact to influence psychiatric disease, treatment, and behavioral research. J Neurosci Res. 2017;95:50–64.
Angst J, Gamma A, Gastpar M, Lepine JP, Mendlewicz J, Tylee A, Depression Research in European Society Study. Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci. 2002;252:201–9.
Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress related disorders? The potential role of sex hormones. Lancet. 2016;4:73–82.
Ruitenberg A, Ott A, Van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22:575–80.
Zhou DF, Wu CS, Qi H, Fan JH, Sun XD, Como P, Qiao YL, Zhang L, Kieburtz K. Prevalence of dementia in rural China: impact of age, gender and education. Acta Neurol Scand. 2006;114:273–80.
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:91–598.
Werlin DM, Geschwindm DH. Understanding sex bias in autism spectrum disorder. Proc Natl Acad Sci. 2013;110:4868–9.
Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49:217–228, e211–e213.
Rucklidge JJ. Gender differences in attention–deficit/hyperactivity disorder. Psychiatr Clin North Am. 2010;33:357–73.
Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157:1015–22.
Woolley CS, Gould E, Frankfurt M, Mcewen BS. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci. 1990;10:4035–9.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74:67–83.
Keyes KM, Cheslack-Postava K, Westhoff C, Heim CM, Haloossim M, Walsh K, Koenen K. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol. 2013;178:1378–88.
Bergemann N, Parzer P, Nagl I, Salbach B, Runnebaum B, Mundt C, Resch F. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch Womens Ment Health. 2002;5:119–26.
McHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol. 2014;1:42–57.
Ciocca G, Limoncin E, Carosa E, Di Sante S, Gravina GL, Mollaioli D, Gianfrilli D, Lenzi A, Jannini EA. Is testosterone a food for the brain? Sex Med Rev. 2016;4:15–25.
Zuloaga DG, Puts DA, Jordan CL, Breedlove SM. The role of androgen receptors in the masculinization of brain and behavior: what we’ve learned from the testicular feminization mutation. Horm Behav. 2008;53:613–26.
Frye CA, Edinger K, Sumida K. Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance. Neuropsychopharmacology. 2008;33:1049–61.
Frye CA, Edinger KL. Testosterone’s metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacol Biochem Behav. 2004;78:473–81.
Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009;4:289–305.
Bandini E, Corona G, Ricca V, Fisher AD, Lotti F, Sforza A, Faravelli C, Forti G, Mannucci E, Maggi M. Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction. J Sex Med. 2009;6:2321–31.
DiBlasio CJ, Hammett J, Malcolm JB, Judge BA, Womack JH, Kincade MC, Ogles ML, Mancini JG, Patterson AL, Wake RW, Derweesh IH. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Can J Urol. 2008;15:4249–56.
Kanayama G, Amiaz R, Seidman S, Pope HG Jr. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharmacol. 2007;15(6):529–38.
Anestis SF. Testosterone in juvenile and adolescent male chimpanzees (pan troglodytes): effects of dominance rank, aggression, and behavioral style. Am J Phys Anthropol. 2006;130:536–45.
Muehlenbein MP, Watts DP, Whitten PL. Dominance rank and fecal testosterone levels in adult male chimpanzees (Pan troglodytes schweinfurthii) at Ngogo, Kibale National Park, Uganda. Am J Primatol. 2004;64:71–82.
Rose RM, Holaday JW, Bernstein IS. Plasma testosterone, dominance rank and aggressive behavior in male rhesus monkeys. Nature. 1971;231:366–8.
Klinkova E, Heistermann M, Hodges JK. Social parameters and urinary testosterone level in male chimpanzees (Pan troglodytes). Horm Behav. 2004;46:474–81.
Fisher AD, Bandini E, Rastrelli G, Corona G, Monami M, Mannucci E, Maggi M. Sexual and cardiovascular correlates of male unfaithfulness. J Sex Med. 2012;6:1508–18.
Fisher AD, Bandini E, Corona G, Monami M, Cameron Smith M, Melani C, Balzi D, Forti G, Mannucci E, Maggi M. Stable extramarital affairs are breaking the heart. Int J Androl. 2012;1:11–7.
Fisher AD, Rastrelli G, Bandini E, Corona G, Balzi D, Melani C, Monami M, Matta V, Mannucci E, Maggi M. Metabolic and cardiovascular outcomes of fatherhood: results from a cohort of study in subjects with sexual dysfunction. J Sex Med. 2012;9:2785–94.
Fisher AD, Corona G, Bandini E, Mannucci E, Lotti F, Boddi V, Forti G, Maggi M. Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunctions. J Sex Med. 2009;6:866–75.
Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C, Hines M. Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Horm Behav. 2007;52:368–74.
Cohen-Bendahan CC, Buitelaar JK, van Goozen SH, Orlebeke JF, Cohen-Kettenis PT. Is there an effect of prenatal testosterone on aggression and other behavioral traits? A study comparing same-sex and opposite-sex twin girls. Horm Behav. 2005;47:230–7.
Ptok U, Barkow K, Heun R. Fertility and number of children in patients with Alzheimer’s disease. Arch Womens Ment Health. 2002;5:83–6.
Barha CK, Galea LA. Motherhood alters the cellular response to estrogens in the hippocampus later in life. Neurobiol Aging. 2011;32:2091–5.
Lund TD, Rovis T, Chung WC, Handa R. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology. 2005;2:797–807.
Walf AA, Frye CA. Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiol Behav. 2010;99:169–74.
Chui HT, Christensen BK, Zipursky RB, Richards BA, Hanratty MK, Kabani NJ, Mikulis DJ, Katzman DK. Cognitive function and brain structure in females with a history of adolescent-onset anorexia nervosa. Pediatrics. 2008;122:426–37.
Misra M, Katzman DK, Estella NM, Eddy KT, Weigel T, Goldstein MA, Miller KK, Klibanski A. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry. 2013;8:e765–71.
Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M, Murad MH, Santoro NF, Warren MP. Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:1413–39.
Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D. A clinical trial of the effect of estrogens in acutely psychotic women. Schizophr Res. 1996;20:247–52.
Kulkarni J, Riedel A, de Castella AR, et al. A clinical trial of adjunctive oestrogen treatment in women with schizophrenia. Arch Womens Ment Health. 2002;5:99–104.
Manji HK, Lenox RH. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic depressive illness. Biol Psychiatry. 1999;46:1328–51.
Haskell SG, Richardson ED. The effect of raloxifene on cognitive function in postmenopausal women: a randomized clinical trial. Conn Med. 2004;68:355–8.
Vercammen A, Skilletere AJ, Lenroot R, Catts SV, Weickert CS, Weickert TW. Testosterone is inversely related to brain activity during emotional inhibition in schizophrenia. PLoS One. 2013;8:e77496.
Goldstein JA. Danazol and the rapid-cycling patient. J Clin Psychiatry. 1986;3:153–4.
Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ, Fava M. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr. 2009;12:688–94.
Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–8.
Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves wellbeing, mood, and sexual function in premenopausal women. Menopause. 2003;10:390–8.
Fisher AD, Castellini G, Ristori J, Casale H, Cassioli E, Sensi C, Fanni E, Amato AM, Bettini E, Mosconi M, Dèttore D, Ricca V, Maggi M. Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data. J Endocrinol Metab. 2016;11:4160–9.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 2DSM-5. Washington DC: American Psychiatric Association; 2013.
Fisher AD, Ristori J, Bandini E, Giordano S, Mosconi M, Jannini EA, Greggio NA, Godano A, Manieri C, Meriggiola C, Ricca V, Italian GnRH analogs study ONIG group, Dettore D, Maggi M. Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG. J Endocrinol Invest. 2014;37:675–87.
Fisher AD, Castellini G, Bandini E, Casale H, Fanni E, Benni L, Ferruccio N, Meriggiola MC, Manieri C, Gualerzi A, Jannini E, Oppo A, Ricca V, Maggi M, Rellini AH. Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. J Sex Med. 2014;3:709–19.
Fisher AD, Bandini E, Casale H, Ferruccio N, Meriggiola MC, Gualerzi A, Manieri C, Jannini E, Mannucci E, Monami M, Stomaci N, Delle Rose A, Susini T, Ricca V, Maggi M. Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med. 2013;10:408–19.
Gorin-Lazard A, Baumstarck K, Boyer L, et al. Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals. J Nerv Ment Dis. 2013;201:996–1000.
Gorin-Lazard A, Baumstarck K, Boyer L, et al. Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med. 2012;9:531–41.
Colizzi M, Costa R, Todarello O. Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology. 2014;39:65–73.
Gómez-Gil E, Zubiaurre-Elorza L, Esteva I, Guillamon A, Godas T, Cruz Almaraz M, Halperin I, Salamero M. Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology. 2012;37:662–70.
Jones BA, Haycraft E, Murjan S, Arcelus J. Body dissatisfaction and disordered eating in trans people: a systematic review of the literature. Int Rev Psychiatry. 2016;28:81–94.
van de Grift TC, Cohen-Kettenis PT, Steensma TD, De Cuypere G, Richter-Appelt H, Haraldsen IR, Dikmans RE, Cerwenka SC, Kreukels BP. Body satisfaction and physical appearance in gender dysphoria. Arch Sex Behav. 2016;3:575–85.
Fleming MZ, MacGowan BR, Robinson L, Spitz J, Salt P. The body image of the postoperative female-to-male transsexual. J Consult Clin Psychol. 1982;50:461–2.
Achermann JC, Hughes IA. Disorders of sex development. In: Kronenberg HM, Melmed S, Polonsky JS, Larsen PRXI, editors. Williams textbook of endocrinology, vol. 22. Philadelphia: Elsevier; 2008. p. 783–848.
Boada R, Janusz J, Hutaff-Lee C, Tartaglia N. The cognitive phenotype in Klinefelter syndrome: a review of the literature including genetic and hormonal factors. Dev Disabil Res Rev. 2009;15:284–94.
Bruining H, Swaab H, Kas M, Van Engeland H. Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics. 2009;123:e865–70.
Fisher AD, Castellini G, Casale H, Fanni E, Bandini E, Campone B, Ferruccio N, Maseroli E, Boddi V, Dèttore D, Pizzocaro A, Balercia G, Oppo A, Ricca V, Maggi M. Hypersexuality, paraphilic behaviors, and gender dysphoria in individuals with Klinefelter’s syndrome. J Sex Med. 2015;12:2413–24.
Ross JL, Roeltgen D, Stefanatos G, et al. Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am J Med Genet A. 2008;146:708–19.
Geschwind DH, Boone KB, Miller BL, et al. Neurobehavioral phenotype of Klinefelter syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:107–16.
Simpson JL, Swerdloff RS, Samango-Sprouse CA, et al. Klinefelter syndrome. In: Cassidy SB, Allanson JE, editors. Management of genetic syndromes. 2nd ed. Hoboken: Wiley-Liss; 2004. p. 323–34.
Dhejne C, Van Vlerken R, Heylens G, Arcelus J. Mental health and gender dysphoria: a review of the literature. Int Rev Psychiatry. 2016;28:44–57.
Murad MH, Elamin MB, Garcia MZ, Mullan RJ, Murad A, Erwin PJ, Montori VM. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol. 2010;72:214–31.
Bockting WO, Goldberg JM. Guidelines for transgender care. Int J Transgenderism. 2006;9:3–4.
Nuttbrock L, Hwahng S, Bockting W, Rosenblum A, Mason M, Macri M, Becker J. Psychiatric impact of gender-related abuse across the life course of male-to-female transgender persons. J Sex Res. 2009;1:12–23.
Auer MK, Hohne N, Bazzara-Castro MA, Pfister H, Fuss J, Stalla GK, et al. Psychopathologic profiles in transsexuals and the challenge of their special status among the sexes. PLoS One. 2013;10:78469.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Fisher, A.D., Ristori, J., Maggi, M. (2018). Pharmachosexology: Use of Sex Hormones in Psychiatric Conditions. In: Jannini, E., Siracusano, A. (eds) Sexual Dysfunctions in Mentally Ill Patients. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-68306-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-68306-5_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68305-8
Online ISBN: 978-3-319-68306-5
eBook Packages: MedicineMedicine (R0)